Overview

Gender

female

Investor Type

Investment Partner

Paula Soteropoulos is the Chairman of the Board of Ensoma. She is a former Founding CEO at Akcea Therapeutics.

Paula is a global strategic and operating management executive with over 20 years of success at building high-performance global teams, leading complex development programs from early stage through approval, and launching global products. Prior to joining Moderna, Paula was the Vice President and General Manager of Genzyme’s Global Cardiovascular business. She was responsible for the development and commercialization of multiple therapeutics across Renal, Transplant & Oncology, Rare Disease, and Cardiovascular.

During her tenure at Genzyme, she was instrumental in advancing new compounds from discovery through clinical development and commercialization with significant roles driving product strategy, portfolio, program and alliance management, sales and marketing and business development. Additionally, Paula led strategic manufacturing capacity planning, supply chain development, and manufacturing process development.

Prior to Genzyme, Paula was a bioprocess engineering consultant for various biopharmaceutical companies. She serves on the Board of Directors of uniQure B.V, a world leader in human gene therapy; the Board of Directors of JFYNet, a non-profit education organization; and the Advisory Board of the Tufts University Chemical and Biological Engineering Department. She is a member of the Healthcare Business Women’s Association and serves as a mentor.

Paula earned her B.S. and M.S. in Chemical and Biochemical Engineering from Tufts University and earned an executive management certificate from Darden School of Business, University of Virginia.

She is a past honoree of Mass High Tech’s Women to Watch.